Literature DB >> 18400911

In vitro replication of varicella-zoster virus in human retinal pigment epithelial cells.

Jonas Schmidt-Chanasit1, Karoline Bleymehl, Holger F Rabenau, Rainer G Ulrich, Jindrich Cinatl, Hans Wilhelm Doerr.   

Abstract

Here we describe for the first time the productive in vitro infection of human retinal pigment epithelial cells by varicella-zoster virus (VZV), resulting in a typical cytopathic effect (CPE) that is characterized by enlarged cells with increased granularity. Depending on the CPE dissemination, high titers of up to 1.6 x 10(6) PFU of cell-free and cryostable VZV/ml can be recovered.

Entities:  

Mesh：

Year:  2008        PMID： 18400911      PMCID： PMC2446866          DOI： 10.1128/JCM.00122-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  West Nile virus infection induces interferon signalling in human retinal pigment epithelial cells.

Authors:  Jindrich Cinatl; Martin Michaelis; Corinna Fleckenstein; Gabriele Bauer; Hanka Kabicková; Martin Scholz; Holger F Rabenau; Hans Wilhelm Doerr
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-02       Impact factor: 4.799

2.  Improved yields of cell-free varicella-zoster virus.

Authors:  N J Schmidt; E H Lennette
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

3.  Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice.

Authors:  R A Santos; C C Hatfield; N L Cole; J A Padilla; J F Moffat; A M Arvin; W T Ruyechan; J Hay; C Grose
Journal:  Virology       Date:  2000-09-30       Impact factor: 3.616

4.  Phenotypic and genetic characterization of thymidine kinase from clinical strains of varicella-zoster virus resistant to acyclovir.

Authors:  F Morfin; D Thouvenot; M De Turenne-Tessier; B Lina; M Aymard; T Ooka
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

5.  Cell-free varicella-zoster virus in cultured human melanoma cells.

Authors:  C Grose; D M Perrotta; P A Brunell; G C Smith
Journal:  J Gen Virol       Date:  1979-04       Impact factor: 3.891

6.  Varicella-zoster virus glycoprotein oligosaccharides are phosphorylated during posttranslational maturation.

Authors:  C A Gabel; L Dubey; S P Steinberg; D Sherman; M D Gershon; A A Gershon
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

7.  High-titre, cryostable cell-free varicella zoster virus.

Authors:  D R Harper; N Mathieu; J Mullarkey
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

8.  Novel approach for genotyping varicella-zoster virus strains from Germany.

Authors:  Jonas Schmidt-Chanasit; Martin Stürmer; Anke Hahn; Susanne G Schäd; Gerd Gross; Rainer G Ulrich; Gerald Heckel; Hans Wilhelm Doerr
Journal:  J Clin Microbiol       Date:  2007-09-12       Impact factor: 5.948

9.  Novel varicella-zoster virus glycoprotein E gene mutations associated with genotypes A and D.

Authors:  Jonas Schmidt-Chanasit; Karoline Bleymehl; Susanne G Schäd; Gerd Gross; Rainer G Ulrich; Hans Wilhelm Doerr
Journal:  J Clin Microbiol       Date:  2007-11-21       Impact factor: 5.948

10.  Growth characteristics and ultrastructure of human retinal pigment epithelium in vitro.

Authors:  M T Flood; P Gouras; H Kjeldbye
Journal:  Invest Ophthalmol Vis Sci       Date:  1980-11       Impact factor: 4.799
View more
  9 in total

1.  Role for the αV Integrin Subunit in Varicella-Zoster Virus-Mediated Fusion and Infection.

Authors:  Edward Yang; Ann M Arvin; Stefan L Oliver
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

2.  Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.

Authors:  Tessa M Campbell; Brian P McSharry; Megan Steain; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2015-05-20       Impact factor: 5.103

3.  Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet.

Authors:  Karoline Bleymehl; Jindrich Cinatl; Jonas Schmidt-Chanasit
Journal:  Med Microbiol Immunol       Date:  2011-03-04       Impact factor: 3.402

Review 4.  A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation.

Authors:  Peter G E Kennedy; Joel Rovnak; Hussain Badani; Randall J Cohrs
Journal:  J Gen Virol       Date:  2015-03-20       Impact factor: 3.891

5.  ORF7 of varicella-zoster virus is a neurotropic factor.

Authors:  Anca Selariu; Tong Cheng; Qiyi Tang; Benjamin Silver; Lianwei Yang; Che Liu; Xiangzhong Ye; Amos Markus; Ronald S Goldstein; Ruth S Cruz-Cosme; Yanzhen Lin; Lanling Wen; Hongliu Qian; Jinle Han; Kalpana Dulal; Ying Huang; Yimin Li; Ningshao Xia; Hua Zhu
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

6.  Comprehensive analysis of varicella-zoster virus proteins using a new monoclonal antibody collection.

Authors:  Tihana Lenac Roviš; Susanne M Bailer; Venkata R Pothineni; Werner J D Ouwendijk; Hrvoje Šimić; Marina Babić; Karmela Miklić; Suzana Malić; Marieke C Verweij; Armin Baiker; Orland Gonzalez; Albrecht von Brunn; Ralf Zimmer; Klaus Früh; Georges M G M Verjans; Stipan Jonjić; Jürgen Haas
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

7.  Productive vs non-productive infection by cell-free varicella zoster virus of human neurons derived from embryonic stem cells is dependent upon infectious viral dose.

Authors:  Anna Sloutskin; Paul R Kinchington; Ronald S Goldstein
Journal:  Virology       Date:  2013-06-12       Impact factor: 3.616

8.  Breadth and Functionality of Varicella-Zoster Virus Glycoprotein-Specific Antibodies Identified after Zostavax Vaccination in Humans.

Authors:  Nicole L Sullivan; Morgan A Reuter-Monslow; Janet Sei; Eberhard Durr; Carl W Davis; Cathy Chang; Megan McCausland; Andreas Wieland; David Krah; Nadine Rouphael; Aneesh K Mehta; Mark J Mulligan; Bali Pulendran; Rafi Ahmed; Kalpit A Vora
Journal:  J Virol       Date:  2018-06-29       Impact factor: 6.549

9.  Analysis of Virus and Host Proteomes During Productive HSV-1 and VZV Infection in Human Epithelial Cells.

Authors:  Werner J D Ouwendijk; Lennard J M Dekker; Henk-Jan van den Ham; Tihana Lenac Rovis; Erik S Haefner; Stipan Jonjic; Jürgen Haas; Theo M Luider; Georges M G M Verjans
Journal:  Front Microbiol       Date:  2020-05-29       Impact factor: 5.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.